Lunch Panel: A Cure for What Ails Us: Celebrating the Impact of Science
Wednesday, May 1, 2013 / 12:30 pm - 2:30 pm


Michael Milken, Chairman, Milken Institute

Nancy Brown, CEO, American Heart Association
Francis Collins, Director, National Institutes of Health
Thomas Frieden, Director, U.S. Centers for Disease Control and Prevention
Andrew von Eschenbach, President, Samaritan Health Initiatives Inc.; former Commissioner, U.S. Food and Drug Administration; former Director, National Cancer Institute

Reasonable people disagree about the specifics of reforming America's complicated system of health care and insurance, but there's no doubt that the best way to cut costs is to prevent people from getting sick in the first place, or to cure them when they fall ill. In an aging nation, nothing would have a greater impact on the federal budget. Bioscience has produced an estimated half of all economic growth for a century by increasing productivity and creating jobs while preventing disease and extending lives. But the best is yet to come: We're at the dawn of a scientific revolution that will reduce care costs and serve as the top driver of economic growth - all while saving, lengthening and improving the quality of lives across the planet. A group of U.S. health leaders joins Institute Chairman Mike Milken for a discussion of the future.